Nephrocare Health Services — 360° view

Nephrocare Health Services, a company in the Healthcare Service Provider industry, reported revenue of ₹303 crore and net profit of ₹34 crore for the September 2026 quarter.

Nephrocare Health Services (NSE: NEPHROPLUS) closed at ₹655.80 on 20 Nov 2026. Its market capitalisation is ₹6,595 crore and it trades at 51.5 times earnings.

Share price
₹655.80 (20 Nov 2026)
Market cap
₹6,595 Cr (20 Nov 2026)
P/E
51.47 (20 Nov 2026)
Revenue
₹303 Cr (September 2026 quarter)
Net profit
₹34 Cr (September 2026 quarter)
ROCE
15.3% (FY26)
ROE
8.83% (FY26)
Book value
₹118 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹781.50 / ₹446.00 (20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: NEPHROPLUS

Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.